Expression of peroxisome proliferator-activated receptor (PPAR)-γ in human lung cancer

被引:0
作者
Inoue, KI
Kawahito, Y
Tsubouchi, Y
Yamada, R
Kohno, M
Hosokawa, Y
Katoh, D
Bishop-Bailey, D
Hla, T
Sano, H
机构
[1] Kyoto Prefectural Univ Med, Dept Internal Med 1, Kamigyo Ku, Kyoto 6028566, Japan
[2] Kyoto Prefectural Univ Med, Dept Surg, Kamigyo Ku, Kyoto 6028566, Japan
[3] Univ Connecticut, Sch Med, Dept Physiol, Ctr Vasc Biol, Farmington, CT 06030 USA
[4] Kyoto Red Cross Hosp, Dept Lab Med & Pathol, Kyoto 6050981, Japan
关键词
peroxisome proliferator-activated receptor-gamma; mRNA; protein; lung cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The peroxisome proliferator-activated receptor (PPAR)-gamma is a member of the steroid nuclear receptors. Recent studies have demonstrated that PPAR-gamma is expressed in several cancer cells. We examined the PPAR-gamma expression in both normal lung and major types of human lung cancer. The expression of PPAR-gamma mRNA was detected in 2 out of 3 normal lung tissues and its protein was detected in 3 out of 5 normal lung tissues. In contrast, a small cell carcinoma cell line and all other types of lung cancer tissues expressed PPAR-gamma mRNA and its protein. Immunoreactive PPAR-gamma is strongly expressed in cancer cells and moderately in mononuclear cells, endothelial cells and fibroblasts of lung cancer tissues. Our results suggest that PPAR-gamma may play an important role in the pathogenesis and/or progression of lung cancer, and may be a novel therapeutical target for therapy of lung cancer.
引用
收藏
页码:2471 / 2476
页数:6
相关论文
共 25 条
[1]   Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].
Auboeuf, D ;
Rieusset, J ;
Fajas, L ;
Vallier, P ;
Frering, V ;
Riou, JP ;
Staels, P ;
Auwerx, J ;
Laville, M ;
Vidal, H .
DIABETES, 1997, 46 (08) :1319-1327
[2]   Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Δ12,14-prostaglandin J2 [J].
Bishop-Bailey, D ;
Hla, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) :17042-17048
[3]   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[4]   Is angiogenesis inhibition the Holy Grail of cancer therapy? [J].
Boehm-Viswanathan, T .
CURRENT OPINION IN ONCOLOGY, 2000, 12 (01) :89-94
[5]   Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [J].
Braissant, O ;
Foufelle, F ;
Scotto, C ;
Dauca, M ;
Wahli, W .
ENDOCRINOLOGY, 1996, 137 (01) :354-366
[6]  
CASTAIGNE S, 1990, BLOOD, V76, P1704
[7]  
Chang TH, 2000, CANCER RES, V60, P1129
[8]   Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages [J].
Chinetti, G ;
Griglio, S ;
Antonucci, M ;
Torra, IP ;
Delerive, P ;
Majd, Z ;
Fruchart, JC ;
Chapman, J ;
Najib, J ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) :25573-25580
[9]   The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression [J].
Guddo, F ;
Fontanini, G ;
Reina, C ;
Vignola, AM ;
Angeletti, A ;
Bonsignore, G .
HUMAN PATHOLOGY, 1999, 30 (07) :788-794
[10]  
ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0